Michel LL, Ziegler P, Kreis P, Hartkopf AD, et al. Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer. Eur J Cancer 2025;227:115689.
PMID: 40780076